July 9, 2025
As the scope of pharmacy practice continues to expand across Canada, pharmacists are taking on increasingly significant roles within the healthcare system. In some provinces, chronic disease management is already part of the pharmacist’s scope, either as part of collaborative practice agreements or as fully independent practitioners, though often limited to a specific set of conditions.
July 2, 2025
MAPflow users can now benefit from enhanced pharmacy delivery capabilities thanks to an innovative integration with MedsOnWheels. This partnership places on-demand delivery services directly at pharmacists' fingertips within the MAPflow platform.
July 2, 2025
This update brings significant improvements to your clinical workflow, enhanced patient documentation capabilities, and important refinements that make your daily pharmacy operations even more efficient.
April 15, 2025
Last month, we had the privilege of spotlighting three outstanding pharmacy leaders who are making a real difference. Whether it's through driving innovation, improving patient care, or advocating for the profession, these individuals exemplify the best of pharmacy.
April 7, 2025
At MAPflow, protecting your health information is our highest priority. We understand the sensitive nature of patient data and have implemented comprehensive security measures that meet or exceed industry standards for healthcare data protection.
March 19, 2025
Andrew Savo, HBSc, PharmD, RPh is a pharmacist and pharmacy manager at Lefroy Pharmacy in Innisfil, Ontario. Here’s a snapshot of a day in his life at the pharmacy, as he walks us through how MAPflow helps him save valuable time and provide better patient care.
April 5, 2024
MAPflow releases updates in response to Ontario Ministry of Health’s change allowing pharmacists in rural pharmacies the opportunity to conduct virtual minor ailment assessments remotely when on-site staffing is limited.
April 5, 2024
MAPflow released an Oseltamivir (Tamiflu) algorithm, in response to the Ontario government regulation authorizing pharmacist to provide further vaccination and treatment options for COVID-19, influenza and Respiratory Syncytial Virus (RSV).